IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 366 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $107,338,401 | +8.0% | 2,366,367 | -2.3% | 0.82% | +24.8% |
Q2 2023 | $99,400,562 | +5.5% | 2,422,631 | -8.1% | 0.66% | +1.5% |
Q1 2023 | $94,253,242 | -6.7% | 2,637,192 | -1.4% | 0.65% | -25.9% |
Q4 2022 | $100,979,530 | -38.5% | 2,673,538 | -28.0% | 0.88% | -23.6% |
Q3 2022 | $164,231,000 | -4.3% | 3,713,107 | -21.0% | 1.14% | +12.8% |
Q2 2022 | $171,691,000 | -24.9% | 4,701,297 | -23.8% | 1.02% | +6.4% |
Q1 2022 | $228,585,000 | +6.1% | 6,171,308 | -12.9% | 0.95% | +46.3% |
Q4 2021 | $215,543,000 | -24.5% | 7,083,256 | -16.8% | 0.65% | -5.0% |
Q3 2021 | $285,472,000 | -19.7% | 8,511,384 | -4.4% | 0.69% | +3.8% |
Q2 2021 | $355,329,000 | +53.7% | 8,907,733 | +73.2% | 0.66% | +44.0% |
Q1 2021 | $231,197,000 | +70.4% | 5,142,271 | +114.3% | 0.46% | +27.1% |
Q4 2020 | $135,671,000 | +468.9% | 2,399,554 | +377.5% | 0.36% | +156.0% |
Q3 2020 | $23,846,000 | +17.5% | 502,560 | +46.0% | 0.14% | -35.3% |
Q2 2020 | $20,290,000 | +258.5% | 344,131 | +187.5% | 0.22% | +54.6% |
Q1 2020 | $5,659,000 | -56.6% | 119,681 | -44.6% | 0.14% | -57.1% |
Q4 2019 | $13,050,000 | +10.8% | 216,025 | +9.8% | 0.33% | +28.0% |
Q3 2019 | $11,782,000 | +16.2% | 196,669 | +24.7% | 0.26% | +0.8% |
Q2 2019 | $10,140,000 | -24.3% | 157,773 | -4.4% | 0.26% | -33.4% |
Q1 2019 | $13,391,000 | +2.2% | 164,978 | -31.9% | 0.38% | -28.0% |
Q4 2018 | $13,099,000 | +10.7% | 242,312 | +5.7% | 0.53% | +49.0% |
Q3 2018 | $11,828,000 | +33.2% | 229,318 | +7.6% | 0.36% | +9.8% |
Q2 2018 | $8,881,000 | -42.7% | 213,127 | -39.4% | 0.32% | -57.8% |
Q1 2018 | $15,512,000 | -16.8% | 351,905 | -5.1% | 0.77% | -48.2% |
Q4 2017 | $18,653,000 | +107.2% | 370,835 | +109.5% | 1.49% | -15.2% |
Q2 2017 | $9,004,000 | +75.6% | 176,991 | +38.7% | 1.75% | +18.6% |
Q1 2017 | $5,128,000 | +1517.7% | 127,563 | +1826.6% | 1.48% | +1185.2% |
Q4 2016 | $317,000 | – | 6,621 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |